SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000914190-19-000169
Filing Date
2019-05-17
Accepted
2019-05-17 16:07:59
Documents
2
Period of Report
2019-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1610
2 NOSEDO POWER OF ATTORNEY nosedapoa.htm EX-24 2243
  Complete submission text file 0000914190-19-000169.txt   5438
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address
Noseda Alessandro (Reporting) CIK: 0001777031 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15070 | Film No.: 19835703